# Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients

> **NCT02267733** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 51 (actual)

## Conditions studied

- Influenza
- Gammopathy

## Interventions

- **DRUG:** Fluzone

## Key facts

- **NCT ID:** NCT02267733
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2016-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02267733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02267733, "Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02267733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*